Objective: This study aims to evaluate the frequency of hydronephrosis and the effect of hydronephrosis on urodynamic parameters in patients with advanced-stage pelvic organ prolapse (POP).
Materials and Methods: This retrospective cross-sectional study was conducted between July 2019 - February 2020 with 66 patients who were admitted to the urogynecology outpatient clinic with symptomatic advanced-stage POP. Urinary system ultrasonography and urodynamic examination were performed on all patients before the operation. The severity of prolapse in the study population was evaluated using the POP-Q system. Urinary system ultrasonography was performed by radiologists. Demographic data, POP time, and urodynamic parameters were compared in hydronephrosis and non-hydronephrosis cases.
Results: The general frequency of hydronephrosis among the patients was 19.7% (13/66 patients). It was found that the weight (p= 0.0001) and body mass index (p= 0.004) levels were higher in patients with hydronephrosis. There was no significant difference in the duration of POP, the presence of detrusor overactivity, and other urodynamic parameters in patients with or without hydronephrosis.
Conclusion: There was no relationship found between hydronephrosis and urodynamic parameters. In line with these data, urinary system ultrasonography is recommended for all patients with POP due to the high frequency of hydronephrosis and the consequences of hydronephrosis leading to renal failure.
Preoperative urodynamics report of patients in both groups was obtained from computer-based hospital records. Detailed anamnesis of these patients, including age, height, weight, body mass index (BMI), parity, and duration of POP (years) were obtained from the files of the patients.
Urinary system ultrasonography with Voluson E8 (General Electrics, USA) device was performed by a radiologist on all of the patients. Urodynamics with prolapse reduction was also performed in these patients. The urodynamic procedure was performed using a multi-channel urodynamic system under International Continence Society (ICS) standards [4]. Uroflowmetry was performed at the beginning and post-void residual (PVR) volume was measured. After bladder evacuation, catheters were placed in the rectum and bladder for filling cystometry. While the patient was in the sitting position, the bladder was filled with sterile saline at room temperature. At the time of filling cystometry, first desire to void, strong desire to void, maximum cystometric capacity, P vesical (Pves), P detrusor (Pdet), P abdominal (Pabd), bladder compliance, detrusor overactivity (DO), valsalva leak point pressure (VLPP), and lowest detrusor pressure at which urinary leakage occurs in the absence of a detrusor contraction or an increase in abdominal pressure (detrusor leak point pressure, DLPP) values were recorded. Detrusor overactivity was considered as involuntary detrusor contraction at any pressure that could occur spontaneously or with stimulation during the filling phase in cytometry. Then, bladder emptying was evaluated by a pressureflow study. In uroflowmetry, maximum flow rate (Qmax), time to reach maximum flow rate, voided volume, and PVR values were recorded. The Liverpool nomogram was used to evaluate uroflowmetry [5]. Study group and control group urodynamic study results (maximal flow rate, time to reach maximum flow rate, void volume, PVR, detrusor overactivity, compliance, maximal vesical pressure, maximal detrusor pressure, maximum bladder capacity, bladder volume at first desire to void, bladder volume at severe desire to void, VLPP, DLPP) were compared with age, parity, and BMI.
Statistical Analysis
In this study, which was carried out to investigate the
effect of hydroureteronephrosis on urodynamic parameters in
patients with POP, 30 patients were reached as a result of the
pilot application designed to compare the PVR levels of the
control group (no hydronephrosis) and the study group (with
hydronephrosis), the potency was found to be 0.82. Based
on this power of influence, a power analysis was made with
GPower 3.1.9.2. As a result of the analysis, in the design of the
comparison of PVR levels between the two groups, the group
ratio was 0.24, 80% power, 95% confidence level, and 0.82
effect power, 52 cases for the control group and 12 cases for the
study group. It was determined that a minimum of 64 cases in
total should be included in the study.
Statistical analysis was performed using the SPSS 23 (statistical package for the social sciences) package program. The demographic variables of patients, the number of units (n), percentage (%), mean, and median (min-max) values were given for continuous variables. The normal distribution test of continuous variables was done with the Kolmogorov Smirnov test. Frequency and percentage values were given for categorical variables. Chi-square analysis was used for the relationships between categorical variables. Where appropriate, categorical variables were evaluated with Fisher's exact test. Independent sample t-test was used for the comparison of two groups in continuous independent variables with normal distribution, and Mann-Whitney U-test was used for two-group comparisons in variables that did not fulfill the normal distribution assumption. P<0.05 value was considered significant.
Table 1: Distribution of hydronephrosis
Detrusor overactivity was detected in 38.46% of patients with hydronephrosis and in 32.08% of patients with hydronephrosis, respectively, and there was no significant difference between the two groups (p=0.746) (Table 2).
Table 2: Detrusor overactivity according to the presence of hydronephrosis
It was determined that the patient group with hydronephrosis had higher weight (p=0.0001) and BMI (p=0.004). There was no significant difference between the two groups in terms of age, parity, and duration of POP (Table 3).
There was also no significant difference found between the two groups in terms of other urodynamic parameters (Table 4).
Table 4: Evaluation of urodynamic parameters according to the presence of hydronephrosis
POP and stress urinary incontinence coexist in up to 80 percent of women with pelvic floor dysfunction [15]. Advancedstage POP can mask urinary incontinence by kinking the urethra. Selection of the optimal reconstructive surgical procedure and adding an anti-incontinence procedure may be challenging to surgeons as the POP repair can unmask urinary incontinence in previously continent women or even worsen the existing urinary symptoms.
There are three possible accepted strategies for potential stress urinary incontinence at the time of symptomatic treatment in women without stress urinary incontinence. One of the strategies is performing concurrent surgeries for POP and stress urinary incontinence, regardless of preoperative POP reduction and urinary stress testing. This will lead to attendant surgical risk, that is unnecessary for the patient. The other one is performing only POP surgery and making another incontinence surgery if needed related to postoperative urinary symptoms. This strategy can lead to a second anesthesiologic preparation. In our clinical practice, we choose the last strategy by performing POP reduction urodynamic testing in combination with medical history for the assessment occult stress urinary incontinence in patients planning POP surgery. We add incontinence surgery if urinary incontinence is demonstrated by prolapse reduction [16].
In our study, a relationship between urodynamic results and the presence of hydronephrosis in POP patients was also investigated, and no significant difference was observed in urodynamic parameters. In other words, it is not possible to predict hydronephrosis based on urodynamic results. Therefore, renal ultrasonography should be performed to investigate the presence of hydronephrosis, even if urodynamics has been performed in patients with POP who are scheduled for followup or surgery.
As a result of the study, there was no significant difference between the duration of POP and the frequency of hydronephrosis. In a study conducted on 140 patients with stage 1-4 prolapse between 2009 and 2012, it was stated that the probability of hydronephrosis increased as the duration of prolapse increased [8]. The reason for this difference may be due to the high number of patients and the inclusion of all stages of POP even the asymptomatic stages in the study.
A significant difference was found between the group with and without hydronephrosis in terms of weight and associated BMI is a valuable secondary result of our study. No similar results were found in previous literature. These results can be attributed to high abdominal pressure which can be a factor in the progression of POP. It can be postulated that high abdominal pressure due to weight may increase hydroureteronephrosis. To understand this relationship more clearly, it should be investigated in more detail with different studies in the future.
In our study, a retrospective analysis was performed on a sample group of 66 people in a local education and training hospital. Although this may be a weakness the study has enough statistical power to press on our valuable finding "the urodynamics does not have the efficient role for the prediction of hydronephrosis in patients with POP". Using a multi-channel urodynamic system following International ICS standards is also a strength of our study. To make a more detailed evaluation of this issue, a larger patient group can be followed and examined for a longer period.
Ethics Committee Approval: Ethics committee approval was received for this study from the ethics committee of University of Health Science, Dr. Sadi Konuk Training and Research Hospital (Approval date and number: 07/09/2020-382).
Informed Consent: Written informed consent was obtained from patients who participated in this study.
Publication: The results of the study were not published in full or in part in form of abstracts.
Peer-review: Externally and internally peer-reviewed. Authorship Contributions: Any contribution was not made by any individual not listed as an author. Concept – F.A., L.Y.; Design - F.A., K.D.; Supervision - L.Y., M.E.; Resources - F.A., E.B.; Materials - F.A., E.B.; Data Collection and/or Processing - F.A., E.B., K.D.; Analysis and/or Interpretation - F.A., E.B., K.D.; Literature Search - F.A., E.B.; Writing Manuscript - F.A., E.B.; Critical Review - L.Y., M.E.
Conflict of Interest: None
Financial Disclosure: The author declared that this study has received no financial support.
1) Maher C, Feiner B, Baessler K, Schmid C. Surgical
management of pelvic organ prolapse in women. Cochrane
Database Syst Rev 2013;2013:CD004014.
https://doi.org/10.1002/14651858.CD004014.pub5.
2) Annie Hui SY, Symphorosa Chan SC, Judy Lam SY,
Lau TK, Tony Chung KH. A prospective study on the
prevalence of hydronephrosis in women with pelvic
organ prolapse and their outcomes after treatment. Int
Urogynecol J 2011;22:1529–34.
https://doi.org/10.1007/s00192-011-1504-2.
3) Dancz CE, Walker D, Thomas D, Özel B. Prevalence of
Hydronephrosis in Women with Advanced Pelvic Organ
Prolapse. Urology 2015;86:250–4.
https://doi.org/10.1016/j.urology.2015.05.005.
4) Rosier PFWM, Schaefer W, Lose G, Goldman HB,
Guralnick M, Eustice S, et al. International continence
society good urodynamic practices and terms 2016:
Urodynamics, uroflowmetry, cystometry, and pressureflow
study. Neurourol Urodyn 2017;36:1243–60.
https://doi.org/10.1002/nau.23124.
5) Haylen BT, Ashby D, Sutherst JR, Frazer MI, West CR.
Maximum and Average Urine Flow Rates in Normal Male
and Female Populations—the Liverposl Nomograms. Br J
Urol 1989;64:30–8.
https://doi.org/10.1111/j.1464-410X.1989.tb05518.x.
6) Beverly CM, Walters MD, Weber AM, Piedmonte MR,
Ballard LA. Prevalence of hydronephrosis in patients
undergoing surgery for pelvic organ prolapse. Obstet
Gynecol 1997;90:37–41.
https://doi.org/10.1016/S0029-7844(97)00240-8.
7) Costantini E, Lazzeri M, Mearini L, Zucchi A, Del Zingaro
M, Porena M. Hydronephrosis and Pelvic Organ Prolapse.
Urology 2009;73:263–7.
https://doi.org/10.1016/j.urology.2008.08.480.
8) Dongol A, Joshi KS, Kc S. Renal impairment among
patients with pelvic organ prolapse in a tertiary care center.
Kathmandu Univ Med J 2013;11:71–4.
https://doi.org/10.3126/kumj.v11i1.11031.
9) Gemer O, Bergman M, Segal S. Prevalence of
hydronephrosis in patients with genital prolapse. Eur J
Obstet Gynecol Reprod Biol 1999;86:11–3.
https://doi.org/10.1016/S0301-2115(99)00052-4.
10) Leanza V, Ciotta L, Vecchio R, Zanghì G, Maiorana A,
Leanza G. Hydronephrosis and utero-vaginal prolapse in
postmenopausal women: Management and treatment. G
Di Chir 2015;36:251–6.
https://doi.org/10.11138/gchir/2015.36.6.251.
11) Wee WW, Wong HF, Lee LC, Han HC. Incidence of
hydronephrosis in severe uterovaginal or vault prolapse.
Singapore Med J 2013;54:160–2.
https://doi.org/10.11622/smedj.2013048.
12) Hadar H, Meiraz S. Total uterine prolapse causing
hydroureteronephrosis. Surg Gynecol Obstet
1980;150:711–4.
13) Lucassen EA, La Chapelle CF, Krouwel E, Groeneveld M.
Renal failure caused by severe pelvic organ prolapse. BMJ
Case Rep 2019;12.
https://doi.org/10.1136/bcr-2019-229318.
14) Siddique M, Ingraham C, Kudish B, Iglesia CB, Polland
A. Hydronephrosis associated with pelvic organ prolapse:
A systematic review. Female Pelvic Med Reconstr Surg
2020;26:212–8. https://doi.org/10.1097/SPV.0000000000000683.